NCT04297865 - Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CJ-15314 Phosphate in Healthy Male Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 24, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

February 28, 2021

Conditions

Healthy

Interventions

DRUG

A dose as CJ-15314

A dose as CJ-15314, 1 capsule

DRUG

B dose as CJ-15314

B dose as CJ-15314, 1 capsule

DRUG

C dose as CJ-15314

C dose as CJ-15314, 1 capsule

DRUG

D dose as CJ-15314

D dose as CJ-15314, 2 capsules

DRUG

E dose as CJ-15314

E dose as CJ-15314, 1 capsule

DRUG

F dose as CJ-15314

F dose as CJ-15314, 2 capsules

DRUG

Placebo

Placebo, 1 capsule

DRUG

Placebo

Placebo, 1 capsule

DRUG

Placebo

Placebo, 1 capsule

DRUG

Placebo

Placebo, 2 capsules

DRUG

Placebo

Placebo, 1 capsule

DRUG

Placebo

Placebo, 2 capsules

Trial Locations (1)

Unknown

RECRUITING

Seoul National University Hospital, Dept. of Clinical Pharmacology, Seoul